{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:36:22Z","timestamp":1740137782412,"version":"3.37.3"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1055\/s-0044-1787299","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T22:31:26Z","timestamp":1717281086000},"page":"791-794","source":"Crossref","is-referenced-by-count":0,"title":["Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?"],"prefix":"10.1055","volume":"124","author":[{"given":"Jordan K.","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-8440","authenticated-orcid":false,"given":"Geoffrey D.","family":"Barnes","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"J A Joglar","year":"2024","journal-title":"Circulation"},{"issue":"19","key":"ref2","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"T L Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jth.12086","article-title":"Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?","volume":"11","author":"R A Rodriguez","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"L Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"23","key":"ref5","doi-asserted-by":"crossref","first-page":"e020904","DOI":"10.1161\/JAHA.121.020904","article-title":"Direct oral anticoagulant adherence of patients with atrial fibrillation transitioned from warfarin","volume":"10","author":"K N Pundi","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jth.15592","article-title":"Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: does low time in therapeutic range affect persistence?","volume":"20","author":"M MA Toorop","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2019.04.023","article-title":"Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study","volume":"179","author":"I Solla-Ruiz","year":"2019","journal-title":"Thromb Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.thromres.2021.11.003","article-title":"Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: findings from the Switching Study","volume":"208","author":"J K Bartoli-Abdou","year":"2021","journal-title":"Thromb Res"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1055\/a-2168-9378","article-title":"Effect of previous INR control during VKA therapy on subsequent DOAC adherence and persistence, in patients switched from VKA to DOAC","volume":"124","author":"T Elling","year":"2024","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1055\/a-2161-0928","article-title":"Prevalence and predictors of nonadherence to direct oral anticoagulant treatment in patients with atrial fibrillation","volume":"7","author":"S FB van der Horst","year":"2023","journal-title":"TH Open"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"A F Ozaki","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1111\/jgs.17423","article-title":"Reasons for nonadherence to the direct oral anticoagulant apixaban for atrial fibrillation","volume":"69","author":"D M Tarn","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/phar.1884","article-title":"Laboratory and clinical monitoring of direct acting oral anticoagulants: what clinicians need to know","volume":"37","author":"S E Conway","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"09","key":"ref14","first-page":"1210","article-title":"Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation","volume":"27","author":"A Charlton","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11239-015-1319-y","article-title":"Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism","volume":"41","author":"D M Witt","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11239-017-1602-1","article-title":"Expanding anticoagulation management services to include direct oral anticoagulants","volume":"45","author":"K W Sylvester","year":"2018","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"ref17","first-page":"e425","article-title":"Time in therapeutic range: warfarin anticoagulation for atrial fibrillation in a community-based practice","volume":"63","author":"D Gateman","year":"2017","journal-title":"Can Fam Physician"},{"issue":"10","key":"ref18","first-page":"1203","article-title":"How to choose an appropriate anticoagulant for cancer-associated thrombosis","volume":"19","author":"J K Schaefer","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"e0194099","DOI":"10.1371\/journal.pone.0194099","article-title":"Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: analysis of overall population and subgroups of prior oral anticoagulant users","volume":"13","author":"C A McHorney","year":"2018","journal-title":"PLoS One"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"e065700","DOI":"10.1136\/bmjopen-2022-065700","article-title":"Comparison of medication adherence to different oral anticoagulants: population-based cohort study","volume":"13","author":"A B Ingason","year":"2023","journal-title":"BMJ Open"},{"issue":"26","key":"ref21","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/bloodadvances.2017012377","article-title":"Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants","volume":"1","author":"J K Schaefer","year":"2017","journal-title":"Blood Adv"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"100175","DOI":"10.1016\/j.jacadv.2022.100175","article-title":"Reasons for nonadherence to the direct oral anticoagulant apixaban","volume":"2","author":"D M Tarn","year":"2023","journal-title":"JACC Adv"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry","volume":"124","author":"S Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018Atrial Fibrillation Better Care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1787299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:57:35Z","timestamp":1730815055000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1787299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":25,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2024,7,19]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1787299","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"type":"print","value":"0340-6245"},{"type":"electronic","value":"2567-689X"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}